Micro- and Nanoparticle-Based Vaccines for Hepatitis B
The incredible success of vaccinations in contributing to public health is undeniable.In fact, vaccines are the most cost-effective public health tool for disease preventionbecause their cost is less than the combined costs of treatment, hospitalization, and time lossfrom work. However, despite the availability of vaccines, cost per dose is a factor limiting thesuccess of global vaccination campaigns, as are the limitations imposed by the need of deliveringmultiple vaccine doses. A number of approaches are being tested particularly for the deliveryof subunit vaccines, and in recent years, a number of groups have devoted their efforts todevelop nano/microparticles prepared from biodegradable and biocompatible polymers asvaccine delivery systems with the goal of inducing both humoral and cellular immune responses.Some important properties of biodegradable polymers are their documented safetyhistory, biocompatibility, and an ability to provide controlled time/rate of antigen release andpolymer degradation. The most extensively studied polymer used for encapsulating vaccineantigens is poly (lactide-co-glycolide acid) (PLGA). This chapter deals in brief with effortstargeting the use of PLGA micro-and nanoparticles for the delivery of hepatitis B surfaceantigen.
KeywordsPLGA Microsphere Tree Shrew PLGA Nanoparticles Oral Immunization PLGA Microparticle
Unable to display preview. Download preview PDF.
- Fong, F.W. (1979) Microsphere production from particle dispersion in polymer solution by adding phase separation agent at low temperature. US Patent US 4, 166, 800.Google Scholar
- He, X., Wang, F., Jiang, L., Li, J., Liu, S., Xiao, Z., Jin, X., Zhang, Y., He, Y., Li, K., Guo, Y. and Sun, S. (2005) Induction of mucosal and systemic immune response by single-dose oral immunization with biodegradable microparticles containing DNA encoding HBsAg. J. Gen. Virol. 86, 601–661.CrossRefPubMedGoogle Scholar
- Kersten, G.F.A. and Kaufmann, G.B. (1996) Biodegradable microspheres as vehicles for antigens. In: W. deGruyter (Eds.) Concepts in Vaccine Development. New York, Springer Publ. Co., pp. 265–302.Google Scholar
- Lavelle, E.C., Grant, G., Pusztai, A., Fuller, U. and O’Hagan, D.T. (2001)Identification of plant lectin with mucosal adjuvant activity. Immunology 102, 77–86.Google Scholar
- McNeela, E., O’Connor, D., Jabbal-Gill, I., Illum, L., Davis, S.S., Pizza, M., Peppoloni, S., Rappuoli, R. and Mills, K.H.G. (2000) A mucosally delivered vaccine against diphtheria: formulation of cross reacting material (CRM197) of diphtheria toxin with chitosan enhances local and systemic and Th2 responses following nasal delivery. Vaccine 19, 1188–1198.CrossRefPubMedGoogle Scholar
- Nuwayser, E.S. and Nucefora, W.A. (1986) Controlled release mi-croparticles comprising core of active ingredient and polymer and coating of the same polymer. US Patent US4, 623, 588.Google Scholar
- Oka, Y., Akbar, S.M., Horiike, N., Joko, K. and Onji, M. (2001) Mechanism and therapeutic potential of DNA-based immunization against the envelope proteins of hepatitis B virus in normal and transgenic mice. Immunology 103, 90–97.Google Scholar
- Park, K., Shalaby, W.S.W. and Park H. (1993) Biodegradable Hydrogels for Drug Delivery. Technomic Publishing Company, Inc., Pennsylvania.Google Scholar
- Singh, P., Prabhakaran, D., Jain, S., Mishra, V., Jaganathan, K.S. and Vyas, S.P. (2004) Cholera toxin B conjugated bile salt stabilized vesicles (bilosomes) for oral immunization Int. J. Pharm. 278, 379–390.Google Scholar
- Spiers, I.D., Eyles, J.E., Baillie, L.W.J., Williamson, E.D. and Oya Alpar, H. (2000) Biodegradable microparticles with different release profiles: effect on the immune response after a single administration via intranasal and intramuscular routes. J. Pharm. Pharmacol. 52, 1195–1201.CrossRefPubMedGoogle Scholar